All In Biotech

Drug Trial Radar · NCT02566993

Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer

Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)

Last checked: Nov 20, 2026Latest source record: Oct 28, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 613 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

613

Actual

Start

Aug 30, 2016

Primary completion

Feb 24, 2020

Study completion Feb 24, 2020

Sponsor

Lead sponsor
PharmaMarIndustry
Sponsor type
Industry
First posted
Oct 2, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase III randomized clinical trial of lurbinectedin (PM01183)/doxorubicin (DOX) versus cyclophosphamide (CTX), doxorubicin (DOX) and vincristine (VCR) (CAV) or topotecan as treatment in patients with small-cell lung cancer (SCLC) who failed one prior platinum-containing line.

Conditions

  • Small-cell Lung Cancer

Interventions

  • Lurbinectedin (PM01183)Drug

  • Doxorubicin (DOX)Drug

  • Cyclophosphamide (CTX)Drug

  • Vincristine (VCR)Drug

  • TopotecanDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Every three months up to death or study termination, a period of approximately 3.5 years

Locations

160 sites in 20 countries. Site status is shown where the registry gives one.

  • Alabama Oncology

    Birmingham, Alabama

  • Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers

    Chandler, Arizona

  • St Jude Hospital Yorba Linda dba St Joseph Heritage Healthcare

    Fullerton, California

  • Loma Linda University Medica! Center

    Loma Linda, California

  • Innovative Clinical Research Institute (ICRI)

    Whittier, California

  • Boca Raton Regional Hospital Lynn Cancer Institute

    Boca Raton, Florida

  • Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center

    Fort Lauderdale, Florida

  • H. Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida

  • Joliet Oncology-Hematology Associates, Ltd.

    Joliet, Illinois

  • Healthcare Research Network III, LLC

    Tinley Park, Illinois

  • Carle Cancer Center

    Urbana, Illinois

  • Norton Cancer Institute

    Louisville, Kentucky

  • Montgomery Cancer Center

    Mount Sterling, Kentucky

  • East Jefferson Hematology-Oncology Metairie Physicians Services, Inc

    Metairie, Louisiana

  • Anne Arundel Medical Center Oncology and Hematology

    Annapolis, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • QUEST Research Institute

    Royal Oak, Michigan

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital

    Lebanon, New Hampshire

  • Summit Medical Group, P.A.

    Florham Park, New Jersey

  • FirstHealth Outpatient Cancer Center

    Pinehurst, North Carolina

  • Gabrail Cancer Center Research

    Canton, Ohio

  • Oklahoma Cancer Specialists and Research Institute, LLC

    Tulsa, Oklahoma

  • Associates in Hematology and Oncology, P.C.

    Upland, Pennsylvania

  • The Center for Cancer and Blood Disorders

    Fort Worth, Texas

  • Tyler Hematology-Oncology PA

    Tyler, Texas

  • Medical Oncology Associates PS (dba Summit Cancer Centers)

    Spokane, Washington

  • MultiCare Institute for Research & Innovation

    Tacoma, Washington

  • Froedtert Hospital & the Medical College of Wisconsin

    Milwaukee, Wisconsin

  • Instituto Oncológico de Córdoba (IONC)

    Córdoba, Argentina

  • CORI - Centro Oncológico Riojano Integral

    La Rioja, Argentina

  • ISIS Centro Especializado de Luce S.A.

    Santa Fe, Argentina

  • Instituto Médico Especializado Alexander Fleming

    C.a.b.a., Buenos Aires, Argentina

  • Centro para la Atención Integral del Paciente Oncológico (CAIPO)

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Universitätsklinik für Innere Medizin III der PMU

    Salzburg, Austria

  • Medizinische Universität Wien / AKH Wien, Universitätsklinik für Innere Medizin I, Abteilung für klinische Onkologie

    Vienna, Austria

  • AZ Maria Middelares

    Ghent, Belgium

  • Clinique André Renard

    Herstal, Belgium

  • CHR de la citadelle

    Liège, Belgium

  • CHU de Liege - Sart Tilman

    Liège, Belgium

Showing 40 of 160 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.